Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Overview:
In this second session of the IVM webinar series, we take a deeper look at the IVM all-in-one intravital microscope. The IVM system is a carefully engineered state-of-the-art intravital fluorescence microscopy platform optimized to perform real-time imaging of dynamic phenomena in in vivo tissues at a cellular level. This technique can serve as a next generation core technology to elucidate the pathophysiology of various human diseases and assist in the discovery of new cures. We will review the different modules of the system allowing for intravital confocal and/or two-photon imaging, along with the features and benefits of each set-up.
Key Features
Key Applications
After attending this webinar, attendees will have an overview of the different modules of the IVM system and an understanding of the features and benefits of each IVM module.
Please join the subsequent parts in this webinar series to learn more about the IVM system, as we dive into the system’s successful applications and perform a live demo showcasing the software and hardware components of the IVM system:
***Note: Please ensure you register for each session in the series. Or email us and we will register you for all 4 sessions.
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders